BiotechTube
Home/Oncoinvent/Tore Kvam
TK

Tore Kvam

Chief Financial Officer

Oncoinvent

Therapeutic Areas

OncologyRadiopharmaceuticals

Oncoinvent Pipeline

DrugIndicationPhase
RadspherinPeritoneal metastasis from ovarian cancerPhase 2b
OI-1 AntibodyPTK7-targeting (various cancers)Pre-clinical

Leadership Team at Oncoinvent

AM
Anders Månsson
Chief Executive Officer
View full Oncoinvent profile